• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同型半胱氨酸对人冠状动脉内皮细胞小窝中小窝蛋白-1和内皮型一氧化氮合酶水平的影响。

Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells.

作者信息

Meye Constanze, Schumann Joerg, Wagner Andrea, Gross Peter

机构信息

Division of Nephrology, Department of Internal Medicine III, Technical University of Dresden, Dresden, Germany.

出版信息

Atherosclerosis. 2007 Feb;190(2):256-63. doi: 10.1016/j.atherosclerosis.2006.03.009. Epub 2006 Apr 17.

DOI:10.1016/j.atherosclerosis.2006.03.009
PMID:16616146
Abstract

One aspect of homocysteine (Hcy) action is the impairment of endothelial cell function due to an impairment of endothelial nitric oxide (NO) production. The activity of the endothelial isoform of NO synthase (eNOS) is regulated by its interaction with caveolin-1 (Cav-1). The aim of this study was to determine whether Hcy may alter the levels of Cav-1 and eNOS in endothelial caveolae. We isolated caveolae-enriched membrane fractions from Hcy-treated human coronary artery endothelial cells. We found that treatment with 500 microM Hcy for 6h significantly reduced the levels of Cav-1 and eNOS in caveolae compared to untreated control by 47+/-7% and by 38+/-14%, respectively. Similarly, long-term incubation (96h) of HCAEC with 100 microM Hcy led to a comparable effect. The decreased Cav-1 abundance in endothelial caveolae in response to Hcy resulted from a decrease in Cav-1 expression at the transcriptional level. The reduced levels of eNOS in caveolae were caused by a translocation of eNOS from the caveolar fractions to noncaveolar fractions. The effects of Hcy were associated with an impairment of stimulated release of NO. These results suggest that Hcy induced impairment of NO production through a modulation of Cav-1 expression associated with a loss of eNOS in caveolae.

摘要

同型半胱氨酸(Hcy)作用的一个方面是由于内皮型一氧化氮(NO)生成受损而导致内皮细胞功能受损。NO合酶(eNOS)的内皮亚型的活性通过其与小窝蛋白-1(Cav-1)的相互作用来调节。本研究的目的是确定Hcy是否可能改变内皮小窝中Cav-1和eNOS的水平。我们从经Hcy处理的人冠状动脉内皮细胞中分离出富含小窝的膜组分。我们发现,与未处理的对照相比,用500 microM Hcy处理6小时可使小窝中Cav-1和eNOS的水平分别显著降低47±7%和38±14%。同样,将人冠状动脉内皮细胞(HCAEC)与100 microM Hcy长期孵育(96小时)也产生了类似的效果。Hcy导致内皮小窝中Cav-1丰度降低是由于转录水平上Cav-1表达减少所致。小窝中eNOS水平的降低是由eNOS从小窝组分向非小窝组分的转位引起的。Hcy的这些作用与NO刺激释放受损有关。这些结果表明,Hcy通过调节与小窝中eNOS丢失相关的Cav-1表达,诱导NO生成受损。

相似文献

1
Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells.同型半胱氨酸对人冠状动脉内皮细胞小窝中小窝蛋白-1和内皮型一氧化氮合酶水平的影响。
Atherosclerosis. 2007 Feb;190(2):256-63. doi: 10.1016/j.atherosclerosis.2006.03.009. Epub 2006 Apr 17.
2
Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.小窝蛋白-1的表达对于血管内皮生长因子诱导的缺血后肢侧支循环形成以及一氧化氮介导的血管生成至关重要。
Circ Res. 2004 Jul 23;95(2):154-61. doi: 10.1161/01.RES.0000136344.27825.72. Epub 2004 Jun 17.
3
Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries.人参皂苷Rb1可阻断同型半胱氨酸诱导的猪冠状动脉内皮功能障碍。
J Vasc Surg. 2005 May;41(5):861-8. doi: 10.1016/j.jvs.2005.01.054.
4
Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells.生长激素释放肽ghrelin可抑制同型半胱氨酸诱导的猪冠状动脉和人内皮细胞的内皮功能障碍。
J Vasc Surg. 2009 Jan;49(1):199-207. doi: 10.1016/j.jvs.2008.08.065. Epub 2008 Nov 22.
5
Endothelial nitric oxide synthase enhancer AVE3085 reverses endothelial dysfunction induced by homocysteine in human internal mammary arteries.内皮型一氧化氮合酶增强剂 AVE3085 可逆转同型半胱氨酸诱导的人内乳动脉内皮功能障碍。
Nitric Oxide. 2018 Dec 1;81:21-27. doi: 10.1016/j.niox.2018.10.001. Epub 2018 Oct 6.
6
The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.钙通道阻滞剂氨氯地平可促进内皮细胞中内皮型一氧化氮合酶(eNOS)从窖蛋白上解离。
Cardiovasc Res. 2006 Aug 1;71(3):478-85. doi: 10.1016/j.cardiores.2006.04.013. Epub 2006 Apr 27.
7
Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.同型半胱氨酸通过损害血管内皮生长因子/ Akt/内皮型一氧化氮合酶信号通路损害血管内皮功能。
Clin Exp Pharmacol Physiol. 2010 Nov;37(11):1071-7. doi: 10.1111/j.1440-1681.2010.05438.x.
8
[The pathogenic mechanism of homocysteine -induced endothelial nitric oxide synthase dysfunction and the antagonistic effects by folic acid].[同型半胱氨酸诱导内皮型一氧化氮合酶功能障碍的致病机制及叶酸的拮抗作用]
Fen Zi Xi Bao Sheng Wu Xue Bao. 2007 Feb;40(1):17-23.
9
Mechanistic studies of AVE3085 against homocysteine in endothelial protection.AVE3085 对同型半胱氨酸致血管内皮保护作用的机制研究。
Cardiovasc Drugs Ther. 2013 Dec;27(6):511-20. doi: 10.1007/s10557-013-6478-5.
10
Vascular effects of linagliptin in non-obese diabetic mice are glucose-independent and involve positive modulation of the endothelial nitric oxide synthase (eNOS)/caveolin-1 (CAV-1) pathway.利格列汀对非肥胖糖尿病小鼠的血管作用不依赖于血糖,且涉及对内皮型一氧化氮合酶(eNOS)/小窝蛋白-1(CAV-1)通路的正向调节。
Diabetes Obes Metab. 2016 Dec;18(12):1236-1243. doi: 10.1111/dom.12750. Epub 2016 Aug 30.

引用本文的文献

1
Association of plasma homocysteine with cardiovascular disease in American adults: a study based on the national health and nutrition examination survey database.美国成年人血浆同型半胱氨酸与心血管疾病的关联:一项基于国家健康与营养检查调查数据库的研究
Front Cardiovasc Med. 2025 Jun 9;12:1528540. doi: 10.3389/fcvm.2025.1528540. eCollection 2025.
2
High-resolution MRI vessel wall enhancement in moyamoya disease: risk factors and clinical outcomes.高分辨率 MRI 血管壁增强在烟雾病中的应用:危险因素和临床转归。
Eur Radiol. 2024 Aug;34(8):5179-5189. doi: 10.1007/s00330-023-10535-0. Epub 2024 Jan 4.
3
RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability.
烟雾病中的RNF213和GUCY1A3:代谢、炎症和血管稳定性的关键调节因子
Front Neurol. 2021 Jul 26;12:687088. doi: 10.3389/fneur.2021.687088. eCollection 2021.
4
Vascular damage effect of circulating microparticles in patients with ACS is aggravated by type 2 diabetes.2 型糖尿病加重 ACS 患者循环微粒体的血管损伤效应。
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12113. Epub 2021 Apr 26.
5
Gastrodin prevents homocysteine-induced human umbilical vein endothelial cells injury via PI3K/Akt/eNOS and Nrf2/ARE pathway.天麻素通过 PI3K/Akt/eNOS 和 Nrf2/ARE 通路预防同型半胱氨酸诱导的人脐静脉内皮细胞损伤。
J Cell Mol Med. 2021 Jan;25(1):345-357. doi: 10.1111/jcmm.16073. Epub 2020 Dec 15.
6
Hydrogen Sulfide Protects Hyperhomocysteinemia-Induced Renal Damage by Modulation of Caveolin and eNOS Interaction.硫化氢通过调节 caveolin 和 eNOS 相互作用保护高同型半胱氨酸血症诱导的肾损伤。
Sci Rep. 2019 Feb 18;9(1):2223. doi: 10.1038/s41598-018-38467-6.
7
Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator.同型半胱氨酸在肾血管并发症中的作用:硫化氢是一种调节剂且可能是厌氧ATP生成剂。
Nitric Oxide. 2014 Sep 15;41:27-37. doi: 10.1016/j.niox.2014.06.006. Epub 2014 Jun 22.
8
C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells.C反应蛋白通过增加低密度脂蛋白跨内皮细胞的转胞吞作用来促进动脉粥样硬化。
Br J Pharmacol. 2014 May;171(10):2671-84. doi: 10.1111/bph.12616.
9
Descriptive study of possible link between cardioankle vascular index and homocysteine in vascular-related diseases.血管相关性疾病中心踝血管指数与同型半胱氨酸之间可能联系的描述性研究。
BMJ Open. 2013 Mar 25;3(3):e002483. doi: 10.1136/bmjopen-2012-002483.
10
The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.人对氧磷酶基因簇作为动脉粥样硬化治疗的靶点。
Antioxid Redox Signal. 2012 Mar 15;16(6):597-632. doi: 10.1089/ars.2010.3774. Epub 2011 Oct 18.